FDA Inspection
Nashat Y Gabrail MDNashat Y Gabrail MD – FDA Inspection, Jan 23, 2020
Record Details
This FDA Inspection record concerns Nashat Y Gabrail MD, with an inspection on January 23, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nashat Y Gabrail MD
- Inspection Date
- January 23, 2020
- Product Type
- Drugs
View Company Profile
ID · a9cf3ef1-bb98-4125-9258-ea5fe9255e97
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1116861
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Nashat Y Gabrail MD
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 15, 2026 | Not classified | Cincinnati District Office | |
| January 21, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 17, 2009 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Nashat Y Gabrail MD
- FDA Inspection 1313094 - 2026-04-15
- FDA Inspection 911090 - 2015-01-21
- FDA Inspection 634783 - 2009-12-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.